CLINICAL_TRIALS
trial_result
· 2020-01-27
Clinical Trial Update: Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Summary
A Phase 2 trial on nonmyeloablative stem cell transplantation for chronic lymphocytic leukemia has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2020-01-27